Meeting
2022 ASCO Annual Meeting
Predictors of overall survival among Black South African men treated with androgen-deprivation therapy for metastatic prostate cancer.
Authors
Yoanna S Pumpalova
Columbia University Irving Medical Center, New York, NY
Yoanna S Pumpalova , Adarsh Ramakrishnan , Shauli Minkowitz , Sean Doherty , Elvira Singh , Audrey Pentz , Wenlong Carl Chen , Alfred I. Neugut , Timothy Rebbeck , Maureen Joffe
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer– Advanced/Castrate-Resistant
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 5046)
DOI
10.1200/JCO.2022.40.16_suppl.5046
Abstract #
5046
Poster Bd #
230
Abstract Disclosures
Similar Posters
Poster
2013 Genitourinary Cancers Symposium
Characterization of patients who present with de novo metastatic prostate cancer: Single-institution database analysis.
First Author: Jessica Strock
Poster
2023 ASCO Genitourinary Cancers Symposium
Comparative outcomes of metastatic prostate cancer (mPC) patients (pts) with DNA damage response gene alterations (DDR-a): A single-center experience.
First Author: Khalid Almunaikh
Poster
2023 ASCO Genitourinary Cancers Symposium
National population-based survival estimates after definitive radiation therapy for prostate cancer.
First Author: Daniel Herr
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Sidedness and addition of chemotherapy associated with treatment outcomes of regorafenib for metastatic colorectal cancer (mCRC).
First Author: Tsung-Che Wu